These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33232507)

  • 21. [A case of myopathy, myocarditis, and encephalitis with nonconvulsive status epileptics after immune checkpoint inhibitor therapy for ureter cancer].
    Akazawa S; Otsuka Y; Hashimoto R; Matsumoto M; Yoneda Y; Kageyama Y
    Rinsho Shinkeigaku; 2022 May; 62(5):395-398. PubMed ID: 35474290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Occurrence of Encephalitis Due to Immune Checkpoint Inhibitors: A Pharmacovigilance Study.
    Chisaki Y; Hata H; Matsumura C; Yano Y
    Ther Innov Regul Sci; 2022 Mar; 56(2):323-332. PubMed ID: 35006589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immunoglobulin for the treatment of childhood encephalitis.
    Iro MA; Martin NG; Absoud M; Pollard AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Immune-Mediated Cerebellitis With Immune Checkpoint Inhibitor Therapy.
    Zurko J; Mehta A
    Mayo Clin Proc Innov Qual Outcomes; 2018 Mar; 2(1):74-77. PubMed ID: 30225435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune checkpoint inhibitor induced anti-glutamic acid decarboxylase 65 (Anti-GAD 65) limbic encephalitis responsive to intravenous immunoglobulin and plasma exchange.
    Chung M; Jaffer M; Verma N; Mokhtari S; Ramsakal A; Peguero E
    J Neurol; 2020 Apr; 267(4):1023-1025. PubMed ID: 31832829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook.
    Möhn N; Beutel G; Gutzmer R; Ivanyi P; Satzger I; Skripuletz T
    J Clin Med; 2019 Oct; 8(11):. PubMed ID: 31653079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature.
    Okada K; Seki M; Yaguchi H; Sakuta K; Mukai T; Yamada S; Oki K; Nakahara J; Suzuki S
    J Neurol; 2021 Feb; 268(2):680-688. PubMed ID: 32909093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.
    Williams TJ; Benavides DR; Patrice KA; Dalmau JO; de Ávila AL; Le DT; Lipson EJ; Probasco JC; Mowry EM
    JAMA Neurol; 2016 Aug; 73(8):928-33. PubMed ID: 27271951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report.
    Taillefer VT; Pigeon M; Chen M; Larochelle C; Florescu M; Bélanger K; Adam JP
    J Oncol Pharm Pract; 2020 Sep; 26(6):1538-1543. PubMed ID: 32063105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of meningoencephalitis that developed during nivolumab use].
    Suzuki Y; Sakurai K; Uchino K; Inoue T; Takahashi T; Hasegawa Y; Yamano Y
    Nihon Ronen Igakkai Zasshi; 2021; 58(4):624-629. PubMed ID: 34880182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Checkpoint Inhibitor Induced Pericarditis and Encephalitis in a Patient Treated With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report and Review of the Literature.
    Braden J; Lee JH
    Front Oncol; 2021; 11():749834. PubMed ID: 34956874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.
    Thouvenin L; Olivier T; Banna G; Addeo A; Friedlaender A
    Ther Adv Drug Saf; 2021; 12():20420986211004745. PubMed ID: 33854755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma.
    Schmidt T; Kebir S; Livingstone E; Junker A; Zülow S; Lazaridis L; Oster C; Chorti E; Pierscianek D; Pul R; Keyvani K; Sure U; Stuschke M; Kleinschnitz C; Scheffler B; Zimmer L; Glas M
    Front Oncol; 2021; 11():637185. PubMed ID: 33937037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Travel-associated neurological disease terminated in a postmortem diagnosed atypical HSV-1 encephalitis after high-dose steroid therapy - a case report.
    Osterman A; Ruf VC; Domingo C; Nitsche A; Eichhorn P; Zimmermann H; Seelos K; Zange S; Dimitriadis K; Pfister HW; Thye T; Giese A; Tappe D; Böhm S
    BMC Infect Dis; 2020 Feb; 20(1):150. PubMed ID: 32070282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system.
    Hu Y; Gong J; Zhang L; Li X; Li X; Zhao B; Hai X
    Int Immunopharmacol; 2020 Jul; 84():106601. PubMed ID: 32422528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofilament light chain levels reflect outcome in a patient with glutamic acid decarboxylase 65 antibody-positive autoimmune encephalitis under immune checkpoint inhibitor therapy.
    Piepgras J; Müller A; Steffen F; Lotz J; Loquai C; Zipp F; Dresel C; Bittner S
    Eur J Neurol; 2021 Mar; 28(3):1086-1089. PubMed ID: 33556229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune checkpoint inhibitor-induced encephalitis with dostarlimab in two patients: Case series.
    Marzoughi S; Chen T
    eNeurologicalSci; 2021 Dec; 25():100356. PubMed ID: 34993356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Risk Factors Associated with Immune Checkpoint Inhibitor-Related Pneumonitis.
    Asada M; Mikami T; Niimura T; Zamami Y; Uesawa Y; Chuma M; Ishizawa K
    Oncology; 2021; 99(4):256-259. PubMed ID: 33477139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognizing encephalopathy in immune checkpoint inhibitor therapy: A single-center experience.
    Wei D; Zhou DJ; Datta P; Taraschenko O
    Cancer Med; 2021 May; 10(9):2978-2986. PubMed ID: 33660430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature.
    Gao Y; Pan J; Shen D; Peng L; Mao Z; Wang C; Meng H; Zhou Q; Chen S
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.